Pure ICL Implantation: A Novel Ophthalmic Viscosurgical Device-Free Method

Purpose. To assess the clinical efficiency of a novel ophthalmic viscosurgical device-free (OVD-free) method for intraocular collamer lens (EVO-ICL) implantation in myopic eyes. Methods. In this study, 40 patients underwent ICL implantation for both eyes: one eye underwent traditional ICL implantati...

Full description

Saved in:
Bibliographic Details
Main Authors: Qin Qin, Lianyun Bao, Zifang He, Feifei Chen, Dandan Zhu, Si Zhang, Wenwen Zhang, Yajun Liu, Ruiying Gao, Zhenggao Xie
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2021/7363267
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560680846229504
author Qin Qin
Lianyun Bao
Zifang He
Feifei Chen
Dandan Zhu
Si Zhang
Wenwen Zhang
Yajun Liu
Ruiying Gao
Zhenggao Xie
author_facet Qin Qin
Lianyun Bao
Zifang He
Feifei Chen
Dandan Zhu
Si Zhang
Wenwen Zhang
Yajun Liu
Ruiying Gao
Zhenggao Xie
author_sort Qin Qin
collection DOAJ
description Purpose. To assess the clinical efficiency of a novel ophthalmic viscosurgical device-free (OVD-free) method for intraocular collamer lens (EVO-ICL) implantation in myopic eyes. Methods. In this study, 40 patients underwent ICL implantation for both eyes: one eye underwent traditional ICL implantation, and the other eye underwent OVD-free (pure) ICL implantation. Preoperative and postoperative UDVA, BCVA, equivalent spherical degree (SE), IOP, visual quality index, subjective visual quality scale, corneal endothelial cell density (ECD), operation time, and complications were compared between and within the traditional and pure ICL implantation groups. Results. Increased IOP >22 mmHg 2 h after surgery was noted in 8 eyes (20%) in the traditional group, but not in the pure group (0%, P<0.001). Increased IOP relative to baseline was significantly higher at 2 h after surgery for the traditional group compared with the pure group (P<0.001). UDVA, BCVA, and SE were significantly improved in the pure group compared with those in the traditional group 1 day (P<0.001, P=0.003) after implantation, but not 1 week or 3 months after. Modulation transfer function cut-off frequency (MTF cut-off), Strehl ratio (SR), and OV20% were significantly better in the pure group than in the traditional group 1 day after implantation (P=0.013, P=0.009, and P=0.004). No significant difference in ECD changes within or between groups was observed (P>0.05). The operation time for the pure group (2.897 ± 0.346 min) was significantly shorter than that for the traditional group (4.444 ± 0.656 min; P<0.001). No complications were reported for either group during the observation period, except early IOP elevation in the traditional group. Conclusions. The pure ICL implantation method was associated with faster visual acuity recovery, shorter operation time, and more stable intraocular pressure. Pure ICL represents a safe and convenient method for ICL implantation compared with the traditional method, completely eliminating OVD-related complications without causing additional complications.
format Article
id doaj-art-922c1e782d784b328660c67fa57c59e7
institution Kabale University
issn 2090-004X
2090-0058
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-922c1e782d784b328660c67fa57c59e72025-02-03T01:27:05ZengWileyJournal of Ophthalmology2090-004X2090-00582021-01-01202110.1155/2021/73632677363267Pure ICL Implantation: A Novel Ophthalmic Viscosurgical Device-Free MethodQin Qin0Lianyun Bao1Zifang He2Feifei Chen3Dandan Zhu4Si Zhang5Wenwen Zhang6Yajun Liu7Ruiying Gao8Zhenggao Xie9Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, Jiangsu, ChinaNanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, Jiangsu, ChinaNanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, Jiangsu, ChinaNanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, Jiangsu, ChinaNanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, Jiangsu, ChinaNanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, Jiangsu, ChinaNanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, Jiangsu, ChinaNanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, Jiangsu, ChinaNanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, Jiangsu, ChinaNanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, Jiangsu, ChinaPurpose. To assess the clinical efficiency of a novel ophthalmic viscosurgical device-free (OVD-free) method for intraocular collamer lens (EVO-ICL) implantation in myopic eyes. Methods. In this study, 40 patients underwent ICL implantation for both eyes: one eye underwent traditional ICL implantation, and the other eye underwent OVD-free (pure) ICL implantation. Preoperative and postoperative UDVA, BCVA, equivalent spherical degree (SE), IOP, visual quality index, subjective visual quality scale, corneal endothelial cell density (ECD), operation time, and complications were compared between and within the traditional and pure ICL implantation groups. Results. Increased IOP >22 mmHg 2 h after surgery was noted in 8 eyes (20%) in the traditional group, but not in the pure group (0%, P<0.001). Increased IOP relative to baseline was significantly higher at 2 h after surgery for the traditional group compared with the pure group (P<0.001). UDVA, BCVA, and SE were significantly improved in the pure group compared with those in the traditional group 1 day (P<0.001, P=0.003) after implantation, but not 1 week or 3 months after. Modulation transfer function cut-off frequency (MTF cut-off), Strehl ratio (SR), and OV20% were significantly better in the pure group than in the traditional group 1 day after implantation (P=0.013, P=0.009, and P=0.004). No significant difference in ECD changes within or between groups was observed (P>0.05). The operation time for the pure group (2.897 ± 0.346 min) was significantly shorter than that for the traditional group (4.444 ± 0.656 min; P<0.001). No complications were reported for either group during the observation period, except early IOP elevation in the traditional group. Conclusions. The pure ICL implantation method was associated with faster visual acuity recovery, shorter operation time, and more stable intraocular pressure. Pure ICL represents a safe and convenient method for ICL implantation compared with the traditional method, completely eliminating OVD-related complications without causing additional complications.http://dx.doi.org/10.1155/2021/7363267
spellingShingle Qin Qin
Lianyun Bao
Zifang He
Feifei Chen
Dandan Zhu
Si Zhang
Wenwen Zhang
Yajun Liu
Ruiying Gao
Zhenggao Xie
Pure ICL Implantation: A Novel Ophthalmic Viscosurgical Device-Free Method
Journal of Ophthalmology
title Pure ICL Implantation: A Novel Ophthalmic Viscosurgical Device-Free Method
title_full Pure ICL Implantation: A Novel Ophthalmic Viscosurgical Device-Free Method
title_fullStr Pure ICL Implantation: A Novel Ophthalmic Viscosurgical Device-Free Method
title_full_unstemmed Pure ICL Implantation: A Novel Ophthalmic Viscosurgical Device-Free Method
title_short Pure ICL Implantation: A Novel Ophthalmic Viscosurgical Device-Free Method
title_sort pure icl implantation a novel ophthalmic viscosurgical device free method
url http://dx.doi.org/10.1155/2021/7363267
work_keys_str_mv AT qinqin pureiclimplantationanovelophthalmicviscosurgicaldevicefreemethod
AT lianyunbao pureiclimplantationanovelophthalmicviscosurgicaldevicefreemethod
AT zifanghe pureiclimplantationanovelophthalmicviscosurgicaldevicefreemethod
AT feifeichen pureiclimplantationanovelophthalmicviscosurgicaldevicefreemethod
AT dandanzhu pureiclimplantationanovelophthalmicviscosurgicaldevicefreemethod
AT sizhang pureiclimplantationanovelophthalmicviscosurgicaldevicefreemethod
AT wenwenzhang pureiclimplantationanovelophthalmicviscosurgicaldevicefreemethod
AT yajunliu pureiclimplantationanovelophthalmicviscosurgicaldevicefreemethod
AT ruiyinggao pureiclimplantationanovelophthalmicviscosurgicaldevicefreemethod
AT zhenggaoxie pureiclimplantationanovelophthalmicviscosurgicaldevicefreemethod